Literature DB >> 34534861

Expanding the toolbox of exosome-based modulators of cell functions.

Qinqin Cheng1, Zhefu Dai1, Xiaojing Shi1, Xinping Duan1, Yiling Wang1, Tianling Hou1, Yong Zhang2.   

Abstract

Exosomes are cell-derived extracellular vesicles and play important roles in mediating intercellular communications. Due to their unique advantages in transporting a variety of biomolecules, exosomes have been emerging as a new class of nanocarriers with great potential for therapeutic applications. Despite advancements in loading chemotherapeutics and interfering RNAs into exosomes, active incorporation of protein molecules into exosomes remains challenging owing to their distinctive physicochemical properties and/or a lack of knowledge of cargo sorting during exosome biogenesis. Here we report the generation of a novel type of engineered exosomes with actively incorporated membrane proteins or soluble protein cargos, named genetically infused functionally tailored exosomes (GIFTed-Exos). Through genetic fusion with exosome-associated tetraspanin CD9, transmembrane protein CD70 and glucocorticoid-induced tumor necrosis factor receptor family-related ligand (GITRL) could be displayed on exosome surface, resulting in GIFTed-Exos with excellent T-cell co-stimulatory activities. By genetically linking to a CD9-photocleavable protein fusion, fluorescent protein mCherry, apoptosis-inducing protein apoptin, and antioxidant enzyme catalase could be effectively packed into exosomes for light-controlled release. The generated GIFTed-Exos display notable in vitro and in vivo activities for delivering distinct types of protein cargos to target cells. As a possibly general approach, GIFTed-Exos provide new opportunities to create exosomes with new functions and properties for biomedical research.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Drug delivery; Exosomes; Nanotechnology; Protein engineering; Synthetic biology

Mesh:

Substances:

Year:  2021        PMID: 34534861      PMCID: PMC8501890          DOI: 10.1016/j.biomaterials.2021.121129

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   15.304


  57 in total

1.  Stimulation by soluble CD70 promotes strong primary and secondary CD8+ cytotoxic T cell responses in vivo.

Authors:  Tania F Rowley; Aymen Al-Shamkhani
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

Review 2.  The Exosome - A Naturally Secreted Nanoparticle and its Application to Wound Healing.

Authors:  Sweta Rani; Thomas Ritter
Journal:  Adv Mater       Date:  2015-12-17       Impact factor: 30.849

3.  hucMSC Exosome-Derived GPX1 Is Required for the Recovery of Hepatic Oxidant Injury.

Authors:  Yongmin Yan; Wenqian Jiang; Youwen Tan; Shengqiang Zou; Hongguang Zhang; Fei Mao; Aihua Gong; Hui Qian; Wenrong Xu
Journal:  Mol Ther       Date:  2017-01-06       Impact factor: 11.454

4.  Exosome-mediated delivery of siRNA in vitro and in vivo.

Authors:  Samir El-Andaloussi; Yi Lee; Samira Lakhal-Littleton; Jinghuan Li; Yiqi Seow; Chris Gardiner; Lydia Alvarez-Erviti; Ian L Sargent; Matthew J A Wood
Journal:  Nat Protoc       Date:  2012-11-15       Impact factor: 13.491

Review 5.  Recent advances in targeted nanoparticles drug delivery to melanoma.

Authors:  Jun Li; Yujue Wang; Ruijing Liang; Xiangjie An; Ke Wang; Guanxin Shen; Yating Tu; Jintao Zhu; Juan Tao
Journal:  Nanomedicine       Date:  2014-12-30       Impact factor: 5.307

6.  Apoptin nuclear accumulation is modulated by a CRM1-recognized nuclear export signal that is active in normal but not in tumor cells.

Authors:  Ivan K H Poon; Cristina Oro; Manisha M Dias; Jingpu Zhang; David A Jans
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

Review 7.  Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery.

Authors:  Vladimir P Torchilin
Journal:  Nat Rev Drug Discov       Date:  2014-10-07       Impact factor: 84.694

8.  Engineering hybrid exosomes by membrane fusion with liposomes.

Authors:  Yuko T Sato; Kaori Umezaki; Shinichi Sawada; Sada-atsu Mukai; Yoshihiro Sasaki; Naozumi Harada; Hiroshi Shiku; Kazunari Akiyoshi
Journal:  Sci Rep       Date:  2016-02-25       Impact factor: 4.379

9.  Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells.

Authors:  Myung Soo Kim; Matthew J Haney; Yuling Zhao; Vivek Mahajan; Irina Deygen; Natalia L Klyachko; Eli Inskoe; Aleksandr Piroyan; Marina Sokolsky; Onyi Okolie; Shawn D Hingtgen; Alexander V Kabanov; Elena V Batrakova
Journal:  Nanomedicine       Date:  2015-11-14       Impact factor: 5.307

10.  The Anti-Apoptotic Effect of ASC-Exosomes in an In Vitro ALS Model and Their Proteomic Analysis.

Authors:  Roberta Bonafede; Jessica Brandi; Marcello Manfredi; Ilaria Scambi; Lorenzo Schiaffino; Flavia Merigo; Ermanna Turano; Bruno Bonetti; Emilio Marengo; Daniela Cecconi; Raffaella Mariotti
Journal:  Cells       Date:  2019-09-14       Impact factor: 6.600

View more
  5 in total

1.  Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes.

Authors:  Qinqin Cheng; Zhefu Dai; Goar Smbatyan; Alan L Epstein; Heinz-Josef Lenz; Yong Zhang
Journal:  Mol Ther       Date:  2022-06-22       Impact factor: 12.910

Review 2.  Exosome-based drug delivery systems and their therapeutic applications.

Authors:  Jaewook Lee; Ji-Heon Lee; Kushal Chakraborty; Joon Hwang; Yong-Kyu Lee
Journal:  RSC Adv       Date:  2022-06-23       Impact factor: 4.036

Review 3.  Reprogramming the tumor microenvironment by genome editing for precision cancer therapy.

Authors:  Ke Liu; Jia-Jia Cui; Yan Zhan; Qian-Ying Ouyang; Qi-Si Lu; Dong-Hua Yang; Xiang-Ping Li; Ji-Ye Yin
Journal:  Mol Cancer       Date:  2022-04-11       Impact factor: 27.401

Review 4.  Research Progress of Exosomes in Bone Diseases: Mechanism, Diagnosis and Therapy.

Authors:  Fanying Meng; Xu Xue; Zhifeng Yin; Fei Gao; Xiuhui Wang; Zhen Geng
Journal:  Front Bioeng Biotechnol       Date:  2022-04-12

Review 5.  Exosomes as Crucial Players in Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Yue Fei; Qi Liu; Na Peng; Guocan Yang; Ziwei Shen; Pan Hong; Shengjun Wang; Ke Rui; Dawei Cui
Journal:  J Immunol Res       Date:  2022-07-20       Impact factor: 4.493

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.